Press releasePRNewswire
Accuray
ARAY · NASDAQ
$0.142−$0.001 (−0.70%)TodayMarket closed ·
Prev close $0.143
Latest news
- NewsNeeraj Jain
Why Is Accuray Stock Gaining Monday?
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- NewsAvi Kapoor
Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
- Press releasePRNewswire
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform
- Press releasePRNewswire
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
- News
Accuray Q4 2026 Earnings Call: Complete Transcript
- News
Accuray Q4 EPS $(0.02) Beats $(0.10) Estimate, Sales $100.919M Miss $105.300M Estimate
- Press releasePRNewswire
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results
- Press releasePRNewswire
Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releasePRNewswire
Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026
- Press releasePRNewswire
Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation
- Press releasePRNewswire
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releasePRNewswire
Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releasePRNewswire
Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026
- Press releasePRNewswire
Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releasePRNewswire
Accuray Reports Fiscal 2026 Second Quarter Financial Results
- Press releasePRNewswire
Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026
- Press releasePRNewswire
Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releasePRNewswire
Accuray Reports Fiscal 2026 First Quarter Financial Results
- Press releasePRNewswire
Accuray Reports Fiscal 2026 First Quarter Financial Results
- Press releasePRNewswire
Accuray Reports Fiscal 2026 First Quarter Financial Results
- Press releasePRNewswire
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
- Press releasePRNewswire
Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025
- Press releasePRNewswire
Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth
- Press releasePRNewswire
Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.